Picture of Innospec logo

IOSP — Innospec News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsBalancedMid CapSuper Stock

Innospec Q2 revenue beats estimates on Fuel Specialties growth

Innospec Q2 revenue beats estimates on Fuel Specialties growth


Overview

  • Specialty chemicals maker's Q2 revenue rose 12%, beating analyst expectations

  • Adjusted EPS for Q2 beat analyst expectations

  • Company repurchased $6.4 mln in shares, ended quarter with over $250 mln net cash


Outlook

  • Company expects further improvement in the second half of 2026 across all business segments

  • Innospec anticipates increased operating cash flow in the second half as working capital efficiency improves

  • Company remains focused on topline growth and margin improvement opportunities for future results


Result Drivers

  • PERFORMANCE CHEMICALS - Operating income rose 15% as positive price/mix and currency effects offset lower volumes

  • FUEL SPECIALTIES - Higher volumes and stable margins contributed to revenue and operating income growth

  • OILFIELD SERVICES - Operating income and margins improved, supported by plant expansion and increased technology adoption


Company press release: ID:nGNX2YpbHp


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Beat

$491.40 mln

$457.23 mln (3 Analysts)

Q2 Adjusted EPS

Beat

$1.27

$1.05 (3 Analysts)

Q2 EPS

$1.25

Q2 Net Income

$30.80 mln

Q2 Gross Profit

$138.30 mln

Q2 Pretax Profit

$41.60 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Innospec Inc is $100.00, about 17% above its August 3 closing price of $85.48

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago


Reuters Recommended Reads

  • Aug 4 - Celanese Q2 adjusted EPS beats estimates, sales meet expectations

  • Aug 3 - Innovex Q2 revenue, adjusted EBITDA beat estimates on international activity

  • Aug 4 - Evonik beats Q2 estimates as European customers seek suppliers close to home amid Iran war


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Innospec

See all news